Keywords: novartis, launches, new, antimalarial, europe, introduced, fixed-dose

Novartis launches new antimalarial in Europe

Article | 31 May 2001

Novartis has introduced a new fixed-dose combination product in Europefor the treatment of uncomplicated malaria caused by Plasmodium falciparum. Riamet ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Artemether Lumefantrine Tablets

Coartem

Go to drug listing